Opiant surges 123% as Indivior set to acquire overdose therapy maker for $145M

November 14, 2022, 11:31 am
Indivior (INVVY) (IZQVF) is acquiring opioid overdose therapy maker Opiant Pharmaceuticals (OPNT) for ~$145M.North Chesterfield, Va.-based Indivior will acquire all outstanding
